Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 2904-2908, July 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pataer, A.
Right arrow Articles by Hiai, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pataer, A.
Right arrow Articles by Hiai, H.

Genetic Resistance to Urethan-induced Pulmonary Adenomas in SMXA Recombinant Inbred Mouse Strains1

Abujiang Pataer, Masahiko Nishimura, Toshiyuki Kamoto, Kentaro Ichioka, Masaaki Sato and Hiroshi Hiai2

Department of Pathology and Biology of Diseases, Kyoto University Graduate School of Medicine, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606 [A. P., T. K., K. I., M. S., H. H.]; and Institute of Experimental Animals, Hamamatsu University School of Medicine, 3600 Handa-cho, Hamamatsu 431-31 [M. N.], Japan

Development of pulmonary adenomas (PAs) in mice is under the genetic control of multiple host genes. We have established a new set of SMXA recombinant inbred strains from PA-susceptible A/J and PA-resistant SM/J mice. The number of urethan-induced PAs was variable among substrains of the SMXA recombinant inbred strains, indicating the involvement of multiple genes. SMXA24 mice were highly resistant to PA, although they had susceptible alleles at all four known susceptibility genes, including kras2 and MHC. To identify the resistance gene in SMXA24, progeny of reciprocal F1 crosses and progeny of backcrosses to A/J were given urethan at 4 weeks of age and examined for induced PA at the age of 5 months. In reciprocal F1 cross progeny, the incidence of PA was very low, indicating that the resistance was a semidominant trait. Quantitative trait analysis of the backcross generation revealed significant linkages to loci on chromosome 12 (logarithm of odds score, 6.47) and chromosome 11 (logarithm of odds score, 4.35). To date, two PA resistance (PAR) genes, Par1 (located on chromosome 11) and Par2 (located on chromosome 18), have been reported. From the map position, one of the resistance genes on chromosome 11 was indistinguishable from Par1. However, another resistance gene on chromosome 12 was new, and we named this gene Par3. A likely candidate gene for Par3 is nPKC{eta}, which is expressed exclusively in skin and lung and is down-regulated in PA. Par1 and Par3 seemed to act synergistically.

1 This study is supported by Grants-in-Aid for General Research and for Cancer Research from the Ministry of Education, Culture and Science, Japan, and from the Japanese Owner's Association, Tokyo, Japan.

2 To whom requests for reprints should be addressed. Phone: 81-075-753-4421; Fax: 81-075-753-4432; E-mail: hiai@med.kyoto-u.ac.jp.

Received 2/13/97. Accepted 5/15/97.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Wang, Z. Zhang, Z. Zhang, H. Vikis, Y. Yan, Y. Wang, and M. You
Fine Mapping and Candidate Gene Analyses of Pulmonary Adenoma Resistance 1, a Major Genetic Determinant of Mouse Lung Adenoma Resistance
Cancer Res., March 15, 2007; 67(6): 2508 - 2516.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Wang and M. You
Five Loci, SLT1 to SLT5, Controlling the Susceptibility to Spontaneously Occurring Lung Cancer in Mice
Cancer Res., September 15, 2005; 65(18): 8158 - 8165.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. K. Bauer, A. M. Malkinson, and S. R. Kleeberger
Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities
Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L685 - L703.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
T. Shimizu, H. Oikawa, J. Han, E. Kurose, and T. Maeda
Genetic Analysis of Crown Size in the First Molars Using SMXA Recombinant Inbred Mouse Strains
J. Dent. Res., January 1, 2004; 83(1): 45 - 49.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Wang, W. J. Lemon, G. Liu, Y. Wang, F. A. Iraqi, A. M. Malkinson, and M. You
Fine Mapping and Identification of Candidate Pulmonary Adenoma Susceptibility 1 Genes Using Advanced Intercross Lines
Cancer Res., June 15, 2003; 63(12): 3317 - 3324.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Kobayashi, T. Ohno, A. Tsuji, M. Nishimura, and F. Horio
Combinations of Nondiabetic Parental Genomes Elicit Impaired Glucose Tolerance in Mouse SMXA Recombinant Inbred Strains
Diabetes, January 1, 2003; 52(1): 180 - 186.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
W J Lemon, H Bernert, H Sun, Y Wang, and M You
Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays
J. Med. Genet., September 1, 2002; 39(9): 644 - 655.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. M. Sargent, J. R. Senft, D. T. Lowry, A. M. Jefferson, F. L. Tyson, A. M. Malkinson, A. E. Coleman, and S. H. Reynolds
Specific Chromosomal Aberrations in Mouse Lung Adenocarcinoma Cell Lines Detected by Spectral Karyotyping: A Comparison with Human Lung Adenocarcinoma
Cancer Res., February 1, 2002; 62(4): 1152 - 1157.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
N. Tripodis, A. A. M. Hart, R. J. A. Fijneman, and P. Demant
Complexity of Lung Cancer Modifiers: Mapping of Thirty Genes and Twenty-five Interactions in Half of the Mouse Genome
J Natl Cancer Inst, October 3, 2001; 93(19): 1484 - 1491.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. D. Dwyer-Nield, B. Paigen, S. E. Porter, and A. M. Malkinson
Quantitative trait locus mapping of genes regulating pulmonary PKC activity and PKC-alpha content
Am J Physiol Lung Cell Mol Physiol, August 1, 2000; 279(2): L326 - L332.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. A. Wardlaw, T. H. March, and S. A. Belinsky
Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions
Carcinogenesis, July 1, 2000; 21(7): 1371 - 1377.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Ogawa, M. Osanai, M. Obata, K. Ishizaki, and K. Kamiya
Gain of chromosomes 15 and 19 is frequent in both mouse hepatocellular carcinoma cell lines and primary tumors, but loss of chromosomes 4 and 12 is detected only in the cell lines
Carcinogenesis, November 1, 1999; 20(11): 2083 - 2088.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Kohno and J. Yokota1
How many tumor suppressor genes are involved in human lung carcinogenesis?
Carcinogenesis, August 1, 1999; 20(8): 1403 - 1410.
[Abstract] [Full Text] [PDF]


Home page
Genome Res.Home page
G. Manenti, A. Stafford, L. De Gregorio, M. Gariboldi, F. S. Falvella, P. Avner, and T. A. Dragani
Linkage Disequilibrium and Physical Mapping of Pas1 in Mice
Genome Res., July 1, 1999; 9(7): 639 - 646.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.